Alken Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Alken Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Alken Asset Management from 13F filings

Historical chart of Alken Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Alken Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Alken Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 1.3k 1189.23
2024-06-30 $1.4M 1.3k 1107.69

More positions owned by Alken Asset Management

Bank of America 7.250 Public (BAC.PL)
PPL Capital Funding 2. Us Domestic (Principal)
Southern Company 3.875 Us Domestic (Principal)
CMS Energy 3.375 01-M Us Domestic (Principal)
InterDigital 3.500 01 Us Domestic (Principal)
FirstEnergy 4.000 01- Us Domestic (Principal)
Palo Alto Networks 0.3 Us Domestic (Principal)
Akamai Technologies 0. Us Domestic (Principal)
NextEra Energy 7.299 Public (NEE.PS)
Nutanix 0.250 01-Oct- Us Domestic (Principal)
Insulet Corp 0.375 01 Us Domestic (Principal)
Zscaler 0.125 01-Jul- Us Domestic (Principal)
Duke Energy 4.125 04/1 Us Domestic (Principal)
Halozyme Thera 1.000 Us Domestic (Principal)
Box 0.000 15-Jan-2026 Us Domestic (Principal)

View all positions for Alken Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1